Abide and Celgene Enter Worldwide License Agreement for ABX-1772

Abide receives upfront payment and potential milestones and royalties SAN DIEGO, March 28, 2018 -- (Healthcare Sales & Marketing Network) -- Abide Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapeutics targeti... Biopharmaceuticals, Licensing Abide Therapeutics, serine hydrolase, Celgene
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news